Olfr487, a member of the G protein-coupled receptor (GPCR) family, is positioned as a crucial player in olfactory sensory perception. Situated on the cell membrane of olfactory sensory neurons, Olfr487 functions as a chemosensory receptor, tasked with the recognition and transduction of specific odorant molecules. In the intricate world of olfaction, Olfr487's primary role is to initiate signaling cascades upon binding to distinct chemical stimuli, thereby orchestrating the transmission of neural signals that contribute to the intricate tapestry of olfactory perception. The receptor's selectivity in detecting and responding to various odorants underscores its significance in shaping an organism's olfactory experience and influencing behavioral responses based on environmental cues.
The inhibition of Olfr487 involves a nuanced interplay of chemical modulators, each meticulously designed to target specific components within intracellular signaling pathways associated with this GPCR. These inhibitors act through diverse mechanisms, finely tuned to disrupt crucial cellular processes. Compounds impacting the MAPK pathway, for instance, exert their influence downstream, modulating elements such as SPRY4, leading to indirect inhibition of Olfr487. Pertussis Toxin interferes with G protein subunits, disrupting GPCR signaling and contributing to Olfr487 inhibition. Additionally, molecules altering intracellular calcium dynamics, like Thapsigargin and Thioridazine, influence calmodulin-associated cascades, indirectly impacting Olfr487 activity. Inhibition through the PI3K-AKT pathway, facilitated by compounds such as Wortmannin and LY294002, showcases the intricate nature of signaling modulation, ultimately influencing Olfr487 function. The diversity in mechanisms highlights the complexity of GPCR inhibition and offers valuable insights into potential avenues for further research in understanding olfactory transduction processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Multikinase inhibitor targeting RAF and VEGFR, indirectly impacting Olfr487 by disrupting downstream signaling cascades. | ||||||
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $451.00 | 3 | |
Inhibits Gαi proteins, affecting GPCR signaling and leading to indirect inhibition of Olfr487. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Induces ER stress by inhibiting SERCA, triggering unfolded protein response (UPR) and influencing Olfr487 activity indirectly. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor disrupting PI3K-AKT pathway, impacting downstream signaling and contributing to Olfr487 inhibition indirectly. | ||||||
OG-L002 | 1357302-64-7 | sc-478221 | 5 mg | $270.00 | ||
Targets Rho kinase, modulating cytoskeletal dynamics and GPCR signaling, indirectly inhibiting Olfr487. | ||||||
Thioridazine | 50-52-2 | sc-473180 | 50 mg | $500.00 | ||
Alters intracellular calcium levels, influencing calmodulin-associated cascades, leading to indirect inhibition of Olfr487. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Selective p38 MAPK inhibitor impacting downstream effectors, contributing to Olfr487 inhibition through the MAPK pathway indirectly. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Src family kinase inhibitor, disrupting downstream signaling pathways and contributing to Olfr487 inhibition indirectly. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
Calmodulin kinase II (CaMKII) inhibitor, influencing calmodulin-associated cascades, leading to indirect inhibition of Olfr487. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor disrupting PI3K-AKT pathway, impacting downstream signaling and contributing to Olfr487 inhibition indirectly. | ||||||